The Cannabis Spread throughout the Continents and its Therapeutic Use in History

Ioannis    A.   Charitos; Roberto       Gagliano-Candela; Luigi       Santacroce; Lucrezia      Bottalico

Abstract

Background: Cannabis sativa L. (C. sativa) is a plant whose use as a therapeutic agent shares its origins with the first Far East’s human societies. Cannabis has been used not only for recreational purposes but as food to obtain textile fibers, to produce hemp paper, to treat many physical and mental disorders.

Aim: This review aims to provide a complete assessment of the deep knowledge of the cannabis psychoactive effects and medicinal properties in the course of history covering i.) The empirical use of the seeds and the inflorescences to treat many physical ailments by the ancient Oriental physicians’ ii.) The current use of cannabis as a therapeutic agent after the discovery of its key psychoactive constituent and the human endogenous endocannabinoid system.

Methods: This study was performed through a detailed analysis of the studies on the historical significance and medical applications of Cannabis sativa by using international scientific databases, historical and medical books, ancient Greek and Chinese manuscripts translations, library and statistical data from government reports and texts from the National Library of Greece (Stavros Niarchos Foundation), from the School of Health Sciences of the National and Kapodistrian University of Athens (Greece). We selected papers and texts focusing on a historical point of view about the medical importance of the plant and its applications for a therapeutic purpose in the past.

Results and Conclusion: Through a detailed analysis of the available resources about the origins of C. sativa, we found that its use by ancient civilizations as a source of food and textile fibers dates back over 10,000 years, while its therapeutic applications have been improved over the centuries, from the ancient East medicine of the 2nd and 1st millennium B.C. to the more recent introduction in the Western world after the 1st century A.D. In the 20th and 21st centuries, Cannabis and its derivatives have been considered as a menace and banned throughout the world, but nowadays, they are still the most widely consumed illicit drugs all over the world. Its legalization in some jurisdictions has been accompanied by new lines of research to investigate its possible applications for medical and therapeutic purposes.

Keywords: Cannabis, cannabinoids, history of medicine, history of cannabis, therapy, drugs, psychopharmacology.

Graphical Abstract

[1] 
Mc Partland, J.M. Cannabis systematics at the levels of family, genus, and species. Cannabis Cannabinoid Res.,  2018, 3(1), 203-212.
[http://dx.doi.org/10.1089/can.2018.0039]] [PMID:  30426073] 
[2] 
ElSohly, M.A.; Mehmedic, Z.; Foster, S.; Gon, C.; Chandra, S.; Church, J.C. Changes in Cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol. Psychiatry,  2016, 79(7), 613-619.
[http://dx.doi.org/10.1016/j.biopsych.2016.01.004] [PMID:  26903403] 
[3] 
Cheng Te-K’un. Archaeology in China; Fleffer & Son: Cambridge, W., 1959, Vol. 1, . 
[4] 
Li, H-L. The origin and use of Cannabis in Eastern Asia linguistic-cultural implications. Econ. Bot.,  1974, 28(3), 293-301.
[http://dx.doi.org/10.1007/BF02861426] 
[5] 
Chang, K.C. The Archaeology of Ancient China; Yale University Press: New Haven, Conn., 1986. 
[6] 
Fairbairn, A.; Martinoli, D.; Butler, A.; Hillman, G. Wild plant
seed storage at Neolithic Çatalhöyük C¸ atalh¨oy¨uk East, Turkey.
Veg. Hist. Archaeobot., 2007, 16, 467-479. 
[http://dx.doi.org/10.1007/s00334-006-0069-3] 
[7] 
Li, H.L.; Lin, H. An archaeological and historical account of cannabis in China. Econ. Bot.,  1974, 28(4), 437-447.
[http://dx.doi.org/10.1007/BF02862859] 
[8] 
Fisher, J. Cannabis in Nepal: an overview. InCannabis and Culture; Rubin, V., Ed.; The Hague Mouton Publishers, 1975. 
[http://dx.doi.org/10.1515/9783110812060.247] 
[9] 
Touw, M. The religious and medicinal uses of Cannabis in China, India and Tibet. J. Psychoactive Drugs,  1981, 13(1), 23-34.
[http://dx.doi.org/10.1080/02791072.1981.10471447] [PMID:  7024492] 
[10] 
Ho, P.T. The loess and the origin of Chinese agriculture. Am. Hist. Rev., 1969, 75(1), 1-36., 
[http://dx.doi.org/10.2307/1841914] 
[11] 
Li, H.L. Hallucinogenic plants in Chinese herbals. J. Psychedelic
Drugs, 1978, 10(1), 17-26. 
[http://dx.doi.org/10.1080/02791072.1978.10471863] 
[12] 
Aldrich, M. History of therapeutic cannabis. Cannabis in medical practice; Mathre, M.L., Ed.; McFarland: Jefferson, NC, 1997, pp. 35-55.
[13] 
Mikuriya, T.H. Marijuana in medicine: past, present and future. Calif. Med.,  1969, 110(1), 34-40.
[PMID:  4883504] 
[14] 
Du Toit, B.M. Cannabis in Africa; Balkema: Rotterdam, 1980. 
[15] 
Du Toit, B.M. Dagga: The history and ethnographic setting of Cannabis sativa in Southern Africa. Cannabis and culture; Rubin, V., Ed.; Mouton: The Hague, 1975. 
[http://dx.doi.org/10.1515/9783110812060.81.] 
[16] 
Parsche, F.; Nerlich, A. Presence of drugs in different tissues of an Egyptian mummy. Fresenius J. Anal. Chem.,  1995, 352, 380-384.
[http://dx.doi.org/10.1007/BF00322236] 
[17] 
Woog, A. The Mysterious and Unknown series: Mummies, Imprint; Reference Point Press, 2009. 
[18] 
Bennet, C. Cannabis and the Soma Solution First edition. Trine Day, LCC,; , 2010. 
[19] 
Butrica, J.L.P. The medical use of cannabis among the Greeks and
Romans. J. Cannabis Ther., 2002, 2(2) 
[http://dx.doi.org/10.1300/J175v02n02_04] 
[20] 
Artamonov, M.I. Frozen Tombs of the Scythians. Scientific. American,,  1965, 212(5), 100-109.
[21] 
Macaulay, G.C. The History of Herodotus, parallel English/Greek, pub; Macmillan: London, NY, 1890. 
[22] 
Emboden, W.A. Jr Ritual use of Cannabis sativa L.: A historical-ethnographic survey. Flesh of the Gods: The Ritual Use of Hallucinogens New York; Furst, P.T., Ed.; , 1972, pp. 214-236.
[23] 
Brunner, T.F. Marijuana in ancient Greece and Rome? The literary evidence. J. Psychedelic Drugs, Drugs. History. and. Culture.,  1977, 9(3), 221-225.
[24] 
Bottalico, L.; Charitos, I.A.; Kolveris, N.; D’Agostino, D.; Topi, S.; Ballini, A.; Santacroce, L. Philosophy and hippocratic ethic in ancient Greek society: evolution of hospital – sanctuaries. Open Access Maced. J. Med. Sci.,  2019, 137(19), 3353-3357.
[http://dx.doi.org/10.3889/oamjms.2019.474]] [PMID: 31949542] 
[25] 
Santacroce, L.; Bottalico, L.; Charitos, I.A. Greek medicine practice at ancient Rome: the physician molecularist Asclepiades. Medicines (Basel),  2017, 124(4)E92
[26] 
Douglas Olson, S. Athenaeus Naucratita, Athenaeus (of Naucratis), The Learned Banqueters: Books III. 106e-V, Loeb classical library; Harvard University Press, 2006. 
[27] 
Barrett, T.H. The Woman Who Discovered Printing; Yale University Press: Great Britain, 2008. 
[28] 
Reardon-Anderson, J. Science and Civilisation in China.Chemistry
and Chemical Technology. Part I. Paper and Printing. By Tsien
Tsuen-Hsuin; Joseph, Needham. Ed.; Cambridge: Cambridge University
Press, 1986, 5, p. 485. The China Quarterly, 108, 733-735 
[29] 
Dioscorides,  Euporista and Materia Medica; Wellman, M., Ed.; 1907-1914.
[30] 
Available at. http://www.poesialatina.it/_ns/greek/testi/Galenus/De_victu_attenuante.html
[31] 
Russo, E.B. The Handbook of Cannabis Therapeutics: From Bench to Bedside; Routledge, 2014. 
[http://dx.doi.org/10.4324/9780203820803] 
[32] 
Habicht, C. Pausanias’ Guide to Ancient Greece, Sather Classical Lectures; University of California Press: Berkeley, Los Angeles, 1985. 
[33] 
Ian, I.; Mayhoff, C. Pliny the Elder. Historia naturalis, ed Stuttgart;, 1967. 
[34] 
Hatsis, T. Psychedelic Mystery Traditions: Spirit Plants, Magical Practices, and Ecstatic States Paperback; Park Street Press, 2018. 
[35] 
Tsagaris, I.M. (Τσαγκαρις Ι.Μ.), The roots of chemistry, The primal
chemistry of ancient Greeks and Byzantines (Οι ριζες της
χημειας, Η πρωτοχημεία των αρχαίων Ελλήνων και των
Βυζαντινών), Faculty of Science, Department of Chemistry (Σχολή
Θετικών Επιστημών, Τμήμα Χημείας), Έκδοση: Πανεπιστήμιο
Ιωαννίνων (Editor: University of Ioannina), Greek edition 2005.http://olympias.lib.uoi.gr/jspui/handle/123456789/7230?mode=full
[36] 
Santacroce, L.; Charitos, I.A.; Bottalico, L. A successful history: probiotics and their potential as antimicrobials. Expert Rev. Anti Infect. Ther.,  2019, 17(8), 635-645.
[http://dx.doi.org/10.1080/14787210.2019.1645597] [PMID:  31318576] 
[37] 
Bouras-Vallianatos, P. Reading Galen in Byzantium: The fate of Therapeutics to Glaucon.Greek Medical Literature and its Readers: From Hippocrates to Islam and Byzantium; Bouras-Vallianatos, P; Xenophontos, S., Ed.; Routledge: Oxon, UK, 2018.  Chapter 9.
Available at:
                    https://www.ncbi.nlm.nih.gov/books/NBK518576/
[http://dx.doi.org/10.4324/9781351205276-10] 
[38] 
Topi, S.; Santacroce, L.; Bottalico, L.; Ballini, A.; Inchingolo, A.D.; Dipalma, G.; Charitos, I.A.; Inchingolo, F. Gastric cancer in history: a perspective interdisciplinary study. Cancers (Basel),  2020, 12(2)E264
[http://dx.doi.org/10.3390/cancers12020264] [PMID:  31978985] 
[39] 
Zuardi, A.W. History of cannabis as a medicine: a review. Braz. J. Psychiatry,  2006, 28(2), 153-157.
[http://dx.doi.org/10.1590/s1516-44462006000200015]] [PMID:  16810401 ] 
[40] 
McCabe, A. A Byzantine Encyclopedia of Horse Medicine: The Sources, Compilation, and Transmission of the Hippiatrica; Oxford University Press, 2007. 
[41] 
Zias, J.; Stark, H.; Sellgman, J.; Levy, R.; Werker, E.; Breuer, A.; Mechoulam, R. Early medical use of cannabis. Nature,  1993, 363(6426), 215.
[http://dx.doi.org/10.1038/363215a0] [PMID:  8387642] 
[42] 
Lozano, I. The therapeutic use of Cannabis sativa (L.) in Arabic medicine. J. Cannabis Ther.,  2001, 1(1), 63-70.
[http://dx.doi.org/10.1300/J175v01n01_05] 
[43] 
Cámara, L. (Indalecio), Acerca de una noticia sobre el qinnab en el
mi’ de Ibnal-Baytar.Ciencias de la Naturaleza en al-Andalus (Textos
y estudios I); García Sánchez, E., Ed.; C.S.I.C.: Granada, 1990,
pp. 151-162. 
[44] 
Welty, T.E.; Luebke, A.; Gidal, B.E. Cannabidiol: promise and pitfalls. Epilepsy Curr.,  2014, 14(5), 250-252.
[http://dx.doi.org/10.5698/1535-7597-14.5.250] 
[45] 
Ford, T.C.; Hayley, A.C.; Downey, L.A.; Parrott, A. C Cannabis: an overview of its adverse acute and chronic effects and its implications. Current. Drug Abuse Reviews.,  2017, 10, 6.
[46] 
Subani, H. The Secret History of Iran., 2013 . Version 1.1..
[47] 
Lewis, A. Historical perspective. Br. J. Addict. Alcohol Other Drugs,  1968, 63(3), 241-245.
[48] 
Brown, D.T. Cannabis: the genus cannabis; Harwood Academic Publisher, 1998, p. 8.
[49] 
Fankhauser, M. History of cannabis in Western Medicine. Cannabis and Cannabinoids; Grotenhermen, F; Russo, E., Ed.; The Haworth Integrative Healing Press: New York, 2002, pp. 37-51.
[50] 
Aldrich, M. History of therapeutic cannabis. Cannabis in Medical Practice; Mathre, M.L., Ed.; McFarland: Jefferson, NC, 1997, pp. 35-55.
[51] 
Pinho, A.R. Social and medical aspects of the use of cannabis in Brazil. Cannabis and Culture; Rubin, V., Ed.; Mounton Publishers: Paris, 1975, pp. 293-302.
[http://dx.doi.org/10.1515/9783110812060.293] 
[52] 
Earleywine, M.; Understanding, M.A.R.I.J.U.A.N.A. a new look at the scientific evidence. Oxford University Press, , 2002. 
[53] 
Santacroce, L.; Bottalico, L.; Topi, S.; Castellaneta, F.; Charitos, I.A. The “Scourge of the Renaissance”. A short review about Treponema pallidum infection. Endocr. Metab. Immune Disord. Drug Targets,  2019, 20(3), 335-343.
[http://dx.doi.org/10.2174/1871530319666191009144217] [PMID:  31625831] 
[54] 
Da Orta, G. Colloquies on the simples & drugs of India (Goa). (Sir
Clements Markham, Trans.); Henru Sotheran: London, 1913.
(Original work published 1563) 
[55] 
Pollio, A. The name of Cannabis: a short guide for nonbotanists. Cannabis Cannabinoid Res.,  2016, 1(1), 234-238.
[http://dx.doi.org/10.1089/can.2016.0027] [PMID:  28861494] 
[56] 
O’Shaughnessy, W.B. A Case of Tetanus, Cured by a Preparation of Hemp (the Cannabis indica.). Transac. Med. Phys. Society Bengal,  1839, 8, 1838-1840.
[57] 
O’Shaughnessy, W.B. On the preparations of the Indian Hemp, or Gunjah: Cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Prov. Med. J. Retrosp. Med. Sci.,  1843, 5(123), 363-369.
[58] 
Moreau, J.J. Du Hachisch et de l’Alienation Mentale: Etudes Psychologiques. Paris: Librarie de Fortin Mason; 1845, English edition; Raven Press: New York, 1972. 
[59] 
Moreau, J.J. Hashish and mental illness; Raven Press: New York, 1973. 
[60] 
Bo, H. Introduction to Moreau de Tours. Hashish and Mental Illness; Peters, H; Nahas, G.G., Ed.; Raven Press: New York, 1973. 
[61] 
Fike, R.E. The Bottle Book: A Comprehensive Guide to Historic, Embossed Medicine Bottles; The Blackburn Press: Caldwell, NJ, 2006. 
[62] 
Sullivan, J. Píso’s Trio: One Step Ahead of the Law. Bottles and
Extras magazine; September-October, 2007, pp. 18-22., 
[63] 
Roffman, R.A. Marijuana as medicine; Madrona Publishers: Seattle, 1982. 
[64] 
Russo, E.B. Cannabis treatments in obstetrics and gynecology: a
historical review. J. Cannabis Therapeutics, 2002, 2(3-4), 5-35. 
[http://dx.doi.org/10.1300/J175v02n03_02] 
[65] 
Terry, C.E. The Harrison anti-narcotic act. Am. J. Public Health (N. Y.),  1915, 5(6), 518.
[http://dx.doi.org/10.2105/AJPH.5.6.518] [PMID:  18009247] 
[66] 
Grinspoon, L. Marihuana reconsidered; Harvard University Press: Cambridge, MA, 1971. 
[67] 
Grinspoon, L.; Bakalar, J.B. Marihuana: the forbidden medicine; Yale University Press: New Haven, 1993. 
[68] 
Brill, H.; Nahas, G.G. Cannabis intoxication and mental illness. Marihuana in science and medicine; Nahas, G.G., Ed.; Raven Press: New York, 1984, pp. 263-306.
[69] 
Musto, D.F. The marihuana tax act of 1937. Arch. Gen. Psychiatry,  1972, 26(2), 101-108.
[http://dx.doi.org/10.1001/archpsyc.1972.01750200005002] [PMID:  4551255] 
[70] 
Gaoni, Y.; Mechoulam, R.J. Isolation structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc.,  1964, 86(8), 1646-1647.
[71] 
Mechoulam, R.J. Marijuana: chemistry, pharmacology and clinical effects; Academic Press: New York, 1973, pp. 2-99.
[72] 
Mechoulam, R.; Parker, L.A.; Gallily, R. Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol.,  2002, 42(S1)(Suppl.), 11S-19S.
[http://dx.doi.org/10.1002/j.1552-4604.2002.tb05998.x] [PMID:  12412831] 
[73] 
Hepler, R.S.; Petrus, R. Experiences with administrations of marijuana to glaucoma patients. The therapeutic potential of marijuana; Cohen, S; Stillman, R., Ed.; Plenum: New York, 1971, pp. 63-76.
[74] 
Inchingolo, F.; Vermesan, D.; Inchingolo, A.D.; Malcangi, G.; Santacroce, L.; Scacco, S.; Benagiano, V.; Girolamo, F.; Cagiano, R.; Caprio, M.; Longo, L.; Abbinante, A.; Inchingolo, A.M.; Dipalma, G.; Tarullo, A.; Tattoli, M. Bedsores successfully treated with topical phenytoin. Acta Biomed.,  2017, 88(1), 45-48.
[http://dx.doi.org/10.23750/abm.v88i1.5794] [PMID:  28467333] 
[75] 
Randall, R.C. (Robert C.) & O’Leary, Alice M Marijuana Rx: the patient’s fight for medicinal pot, 1st ed; Thunder's Mouth Press: New York, 1998. 
[76] 
Cagiano, R.; Bera, I.; Sabatini, R.; Flace, P.; Vermesan, D.; Vermesan, H.; Dragulescu, S.I.; Bottalico, L.; Santacroce, L. Effects on rat sexual behaviour of acute MDMA (ecstasy) alone or in combination with loud music. Eur. Rev. Med. Pharmacol. Sci.,  2008, 12(5), 285-292.
[PMID: 19024211] 
[77] 
Zimmer, L.; Morgan, J.P. Marijuana myths marijuana facts; The Lindesmith Center: New York, 1997. 
[78] 
Rosenthal, E.; Kubby, S. Why marijuana should be legal; Thunder’s Mouth: New York, 1996. 
[79] 
Zou, S.; Kumar, U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int. J. Mol. Sci.,  2018, 19(3), 833.
[http://dx.doi.org/10.3390/ijms19030833] [PMID:  29533978] 
[80] 
Gonçalves, J.; Rosado, T.; Soares, S.; Simão, A.Y.; Caramelo, D.; Luís, Â.; Fernández, N.; Barroso, M.; Gallardo, E.; Duarte, A.P. Cannabis and its secondary metabolites: their use as therapeutic drugs, toxicological aspects, and analytical determination. Medicines (Basel),  2019, 6(1), 31.
[http://dx.doi.org/10.3390/medicines6010031] [PMID:  30813390] 
[81] 
Penner, I.K.; Hartung, H.P. The dark side of the moon: looking beyond beneficial effects of cannabis use in multiple sclerosis. Brain, 2019, 142(9), 2552-2555., 
[http://dx.doi.org/10.1093/brain/awz234] 
[82] 
Feinstein, A.; Meza, C.; Stefan, C.; Staines, R.W. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. Brain,  2019, 142(9), 2800-2812.
[http://dx.doi.org/10.1093/brain/awz213] [PMID:  31363742] 
[83] 
Wills, S. Cannabis use and abuse by man: an historical perspective., Cannabis, taylorfrancis.com 1998.
[84] 
Kandel, D.B. Marijuana users in young adulthood. Arch. Gen. Psychiatry,  1984, 41(2), 200-209.
[http://dx.doi.org/10.1001/archpsyc.1984.01790130096013] [PMID:  6607718] 
[85] 
U.S. Department of Health & Human Services - SAMHSA. Know the Risks of Marijuana.,  Available at:
                    https://www.samhsa.gov/
                    marijuana (Accessed February 29, 2020)
[86] 
European Drug Report. European Monitoring Centre for Drugs and
Drugs Addiction (EMCDDA) Annual Report 2019: "The state of
the drugs problem in the European Union and Norway". 1-98. http://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDAT19001ENN_PDF.pdf

Cite As

Endocrine, Metabolic & Immune Disorders - Drug Targets

The Cannabis Spread throughout the Continents and its Therapeutic Use in History

Abstract

Graphical Abstract